Tumor-associated tertiary lymphoid structure predicts postoperative outcomes in patients with primary gastrointestinal stromal tumors
Tumor-infiltrating tertiary lymphoid structures (TLS) are thought to have anti-tumor activity and are believed to indicate a favorable prognosis in cancer patients. However, the prognostic value of TLS in gastrointestinal stromal tumors (GIST) is unknown. We evaluated the prognostic value of TLS usi...
Main Authors: | Qiaowei Lin, Ping Tao, Jiongyuan Wang, Lijie Ma, Quan Jiang, Jinglei Li, Ge Zhang, Ju Liu, Yong Zhang, Yingyong Hou, Weiqi Lu, Ruyi Xue, Hanxing Tong |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2020.1747339 |
Similar Items
-
Current Management of Gastrointestinal Stromal Tumor
by: Gautam Shubhankar, et al.
Published: (2020-01-01) -
Gastrointestinal stromal tumor of rectum- a case report
by: Madhuri S.Kate, et al.
Published: (2012-11-01) -
Sarcomas del estroma gastrointestinal tratados con Imatinib®: presentación de 2 casos Gastrointestinal stromal tumors treated with Imatinib®: report of 2 cases
by: Mayté Lima, et al.
Published: (2006-06-01) -
MORPHOLOGICAL AND IMMUNOCYTOCHEMICAL CHARACTERISTICS OF STROMAL GASTROINTESTINAL TUMORS
by: Ivan Ilić, et al.
Published: (2010-09-01) -
Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
by: Shang-Yu Wang, et al.
Published: (2019-03-01)